NOTI CES
`
`'
`
`"(hwid ntio, 2.00; 95% Cl. 1.13 to 355; P=0.02)," and "(h
`aiard
`. 4 96· 95<1, Cl 2.39 to 10.3; P<0.001)," rather th•
`, n '(ha
`•
`•
`111110,
`2ard
`l 9g. 95% Cl. 1.1110 3.51; P=0.02)." The article.
`.
`is corrcc
`r3uo, .
`'
`t
`at NEJM.org.
`Chimeric Antigen Receptor-Modified T Cells in Chronic l
`pboid Leukemia (August 25, 2011;365:725-33), Chimeric An _Yrn(cid:173)
`t:lgen
`n . ptor-Modified T Cells for Acute l ymphoid ~ukcm·
`1a CAp .1
`.
`•
`.
`.,_ecc
`n
`20l3;368:1509·18), Ch1mer1c Anugen R.eccptorT Cell fi
`s or su
`b
`18
`.
`.
`. .
`,
`s-
`cained Remissions ,n Leukemia (OclO er 16, 2014;371,1507_
`1
`7l.
`.
`Tbree articles omitted an acknowledgment of work as
`sociated
`.
`h
`.
`.
`.
`'th rhe chimeric anugen receptor c at was used 10 the
`.
`~
`The acknowledgments at the end of each article should h ·
`ave
`included 1he following sentence: "Ors. Dario Campa
`'
`.
`na and
`d
`.
`Chiba"" Jmai and others at St. Ju e Ch,ldrc.n s Research H
`ospotaJ
`'d
`,-
`designed. developed, and prov, ed under material tr
`ansfcr
`(C
`.
`.
`.
`agreements the cb1m~nc anugen receptor AR) that was Used
`in chis study." The arucles are correct at NEJM.org.
`
`Ill
`
`NOTICES
`
`-~
`7]
`a racing ti me of 9 hours or more appear to be ![ _________________ _JI
`
`race. The first cast>S of hyponatremia appeared
`ti · h d . the
`in the cluster of participants who ms e in
`9th hour of the race; cases of critical hyponatre·
`ts who
`· ·
`mia occurred in the clusrers of paruc1pan
`finished in the 12th and 14th hours of the race.
`A previous srudy im·olving marathon runners
`showed that 12 to 13% of participants had by·
`ponatremia and that the incidence of critical
`hyponarremia was 0.5 to 1%.1 In contrast, the
`observed incidence of hyponatremia in long·
`distance triathlons was 10.6%. The incidence of
`critical hyponatremia was 03% (approximately
`half the incidence seen among marathoners).
`Our data show that exercise-associated hypona·
`tremia occurs in a considerable percentage of
`long-distance triathletes. Female triathletes with
`
`the most susceptible to hyponatremia.
`Matthias Danz, M .D.
`St Martonus Hospotal
`Olpe, Germany
`Jochen Hinkelbein, M.D.
`Stefan Braunecker, M.D.
`Un,v,rs,ty Hospotal of Cologn•
`Cologne, Germany
`stcfan.braun,cker@uk-koeln de
`and Others
`A romplete list of authors is avail•ble with the full text of this
`lerter at N EJM.org.
`Supported by Radiometer, which provided 2 blood-gas analyzer
`during the rompetinon.
`Dosdosure forms provided by the authors are available with
`the full ccxr of this letter at NEJM.org.
`
`1. Almond CS, Shin AY, Fortescue EB, er al. Hyponarremia
`among runners m the Boston Marathon. N Engl J Med 2005:352:
`1550-6.
`2. Davis DP, Videen JS, Manno A, et al. Exercise•associared
`byponacremi2 in marathon runners: a rwo-year experience.
`J Em•_rg Med 2001;21:47-57.
`3. Menier S. Rusch C, Frey WO. ct al. Hyponatremia among run(cid:173)
`ners in the Zurich Marathon. Clio J Sport Med 2008;18:344-9.
`4. Hew TD. Chorley JN, Cianc:a JC, er al The ,ncidenct, risk
`actors, and clonic:al manifestations of hyponmemia in mara•
`tbon runners. Clon J Spon Med 2003:13:41-7.
`DOI. 10.1056/NEJMc.Ul0409
`~ cn a eo,,y,,,/rt C 20l 6 M--i..s.m MtdoUJI s«,,1y
`
`Notice.s submitted for publication should contain a mailing
`addrtsS and telephone number of a contact person or depart(cid:173)
`ment. Wt regret that we are unable to publish all notius
`received. Notices also appear on the Journal's website
`(NEJM.org/mtdical-conference). The listin9s can bt viewed
`in their entirety or Jilttrtd by specialty, location, or month.
`
`MATERNAL, FETAL, AND NEONATAL CARE CONFERENCE
`The following conference will be held: "XXV European Con(cid:173)
`gress on Perinatal Medicine• (Maascricht, the Netherlands
`'
`June 15-18).
`Contact MCA Scientific Events, Via Binda 34, 20143 Milan,
`lraly; or call (39) 2 34934404; or f:u (39) 2 34934397; or e-mail
`lucrti@mcascientificevmts.cu or dircnzo@mc:ascicnrificc,-cnts.eu;
`or see http://www.ecpm20l6.eu.
`
`CALL FOR APPLICATIONS
`The French Hemophilia Society is accepting applic:11ions for
`irs ·Henri Chaigne2u Prize," which supports research work in
`hem~philia and von Willebrand disease genetics, diagnosis,
`phys1opa1hology, and therapeutics. Deadline for submission is
`Dec. 31.
`Contact l'Association Fran~aise des Hcmophiles, 6 rue Alex·
`andre Cabanel, 75739 Paris CEDEX 15, France; or call (33) I
`45-677767; or fax (33) 145-677767; or e-mail info(ii)a fh.asso.fr;
`or see http://www.afh.asso.fr.
`
`COMPUTER ASSISTED RADIOLOGY AND SURGERY
`CONGRESS (CARS 2016)
`The congress will 1ake place in Heidelberg Germany June
`. '
`'
`22- 25.
`
`_ _ _ _ _ _ _ _ _ _ _ _ _ _ __ _ _ JI Contact Franziska Schweikert, CAR..S Conference Office, Im
`
`CORRECT IONS
`
`I L.I
`
`] Gur 15, 79790 Kuessaberg, Germany; or call (49) 7742-922 434;
`or fa~ (49) 7742-922 438; or e-mail office@lcars-int.org; or see
`http://www.c;irs-int.org.
`
`Subclinical Atria.I Fibnllation and the Risk ofStr0ke Uanuary 12,
`20U,366:120-9). In the Stroke or Systemic Embolism sub&ecrion
`of Results (page 123), the first rwo sentences of1he second para(cid:173)
`graph tncluded tnaccurate hazard ratoos, 95.,_ confidence inter(cid:173)
`vals, and P values. In the first sencenci,, the parentheucal should
`ba,oe rud, "(hazard ratio, 1.77; 95"' Cl, 1.01 10 3.10; P=0.047) •
`rather clun "(hazard ratio, 1.76: 95"' Cl, 0.99 to 3.11; P=0.05):.
`d
`In the second semence, the parcorhecials should have
`rea ,
`.
`rd
`• L .
`rauo, 2.99; 9~ CJ, 1.55 to 5.77; P=0.001)," rather than
`( .... za
`
`[
`
`THI JOU.HAL'S wn AN D E•MAIL ADDRESSES
`To sub~ita lener to the Editor: authors.NEJM.org
`For onformauon about the status of a submirred manuscript:
`authocs.NEJM.org
`To submit a meeting nolicc: meelingnotices(ii)NEJM.org
`The Joumol's web pages: NE)M.org
`
`998
`
`' • l '•Ci\J .. (0 37~.IO NlJM ORC
`
`lolAACl1 10, 2016
`
`◄
`
`Miltenyi Ex. 1027 Page 1
`
`